Journal of Applied Physiology, Vol 75, Issue 4 1471-1476, Copyright © 1993 by American Physiological Society

ARTICLES

Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle

C. E. Torgan, G. J. Etgen Jr, J. T. Brozinick Jr, R. E. Wilcox and J. L. Ivy
Department of Kinesiology, University of Texas, Austin 78712.

The effects of aerobic exercise training, chronic administration of the selective beta 2-adrenergic agonist clenbuterol, and the combination of these two treatments on muscle insulin resistance were compared in female obese (fa/fa) Zucker rats. Rats were randomly assigned to trained, clenbuterol, clenbuterol-trained, or control groups. Training consisted of treadmill running for 2 h/day at 18 m/min up an 8% grade. Clenbuterol was administered by intubation (0.4-0.8 mg.kg body wt-1 x day-1) approximately 30 min before the rats ran each day. After 8 wk of treatment, muscle insulin resistance was assessed via hindlimb perfusion in the presence of 8 mM glucose and a submaximal (500 microU/ml) insulin concentration. Training increased citrate synthase activity (mumol.g wet wt-1 x min-1) by 32-74% and insulin-stimulated glucose uptake by 45%. Clenbuterol ingestion induced a 17-29% increase in muscle mass but decreased citrate synthase activity by 34-42% and had no effect on muscle glucose uptake. Administration of clenbuterol to rats that exercise trained prevented the training-induced improvement in insulin-stimulated glucose uptake and attenuated the increases in citrate synthase activity. In addition, both clenbuterol-treated groups displayed a 42% decrease in beta-adrenergic receptor density. The results indicate that clenbuterol administration, possibly through beta-adrenergic receptor downregulation, attenuated a cellular reaction essential for the exercise training-induced increase in citrate synthase activity and improvement in skeletal muscle insulin resistance of the obese Zucker rat.

This article has been cited by other articles:

				G. S. Lynch and J. G. Ryall Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease Physiol Rev, April 1, 2008; 88(2): 729 - 767. [Abstract] [Full Text] [PDF]

				D. J. Baker, D. Constantin-Teodosiu, S. W. Jones, J. A. Timmons, and P. L. Greenhaff Chronic Treatment with the beta2-Adrenoceptor Agonist Prodrug BRL-47672 Impairs Rat Skeletal Muscle Function by Inducing a Comprehensive Shift to a Faster Muscle Phenotype J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 439 - 446. [Abstract] [Full Text] [PDF]

				K. Malinowski, C. F. Kearns, P. D. Guirnalda, V. Roegner, and K. H. McKeever Effect of chronic clenbuterol administration and exercise training on immune function in horses J Anim Sci, December 1, 2004; 82(12): 3500 - 3507. [Abstract] [Full Text] [PDF]

				D. G. Hunt, Z. Ding, and J. L. Ivy Clenbuterol prevents epinephrine from antagonizing insulin-stimulated muscle glucose uptake J Appl Physiol, March 1, 2002; 92(3): 1285 - 1292. [Abstract] [Full Text] [PDF]

				T. Kitaura, N. Tsunekawa, and H. Hatta Decreased monocarboxylate transporter 1 in rat soleus and EDL muscles exposed to clenbuterol J Appl Physiol, July 1, 2001; 91(1): 85 - 90. [Abstract] [Full Text] [PDF]

				S. J. Pan, J. Hancock, Z. Ding, D. Fogt, M. Lee, and J. L. Ivy Effects of clenbuterol on insulin resistance in conscious obese Zucker rats Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E554 - E561. [Abstract] [Full Text] [PDF]

				P. Rajab, J. Fox, S. Riaz, D. Tomlinson, D. Ball, and P. L. Greenhaff Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R1076 - R1081. [Abstract] [Full Text] [PDF]